Compile Data Set for Download or QSAR
Report error Found 154 Enz. Inhib. hit(s) with all data for entry = 10669
TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4D(Human)
Union Therapeutics

US Patent
LigandPNGBDBM558646(US11365204, Example 1 | [1-[(5R)-5-Oxido-4-(tetrah...)
Affinity DataIC50: 100nMAssay Description:The human PDE4D catalytic domain (UniProt no. Q08499 [S380-L740]) was incubated with a mixture of non-labelled cAMP (cyclic adenosine monophosphate) ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2022
Entry Details
Go to US Patent

TargetTumor necrosis factor(Human)
Union Therapeutics

US Patent
LigandPNGBDBM558646(US11365204, Example 1 | [1-[(5R)-5-Oxido-4-(tetrah...)
Affinity DataIC50: 100nMAssay Description:Human peripheral blood mononuclear cells (PBMC) were isolated from fresh buffy coats by density centrifugation using lymphoprep tubes (Medinor). Froz...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2022
Entry Details
Go to US Patent

TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4D(Human)
Union Therapeutics

US Patent
LigandPNGBDBM558647(US11365204, Example 2 | [1-[(5R)-5-Oxido-4-(tetrah...)
Affinity DataIC50: 100nMAssay Description:The human PDE4D catalytic domain (UniProt no. Q08499 [S380-L740]) was incubated with a mixture of non-labelled cAMP (cyclic adenosine monophosphate) ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2022
Entry Details
Go to US Patent

TargetTumor necrosis factor(Human)
Union Therapeutics

US Patent
LigandPNGBDBM558647(US11365204, Example 2 | [1-[(5R)-5-Oxido-4-(tetrah...)
Affinity DataIC50: 100nMAssay Description:Human peripheral blood mononuclear cells (PBMC) were isolated from fresh buffy coats by density centrifugation using lymphoprep tubes (Medinor). Froz...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2022
Entry Details
Go to US Patent

TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4D(Human)
Union Therapeutics

US Patent
LigandPNGBDBM558648(US11365204, Example 3 | [1-[4-[Methyl(tetrahydropy...)
Affinity DataIC50: 100nMAssay Description:The human PDE4D catalytic domain (UniProt no. Q08499 [S380-L740]) was incubated with a mixture of non-labelled cAMP (cyclic adenosine monophosphate) ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2022
Entry Details
Go to US Patent

TargetTumor necrosis factor(Human)
Union Therapeutics

US Patent
LigandPNGBDBM558648(US11365204, Example 3 | [1-[4-[Methyl(tetrahydropy...)
Affinity DataIC50: 100nMAssay Description:Human peripheral blood mononuclear cells (PBMC) were isolated from fresh buffy coats by density centrifugation using lymphoprep tubes (Medinor). Froz...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2022
Entry Details
Go to US Patent

TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4D(Human)
Union Therapeutics

US Patent
LigandPNGBDBM558649(US11365204, Example 4 | [1-[(5R)-4-[Methyl(tetrahy...)
Affinity DataIC50: 100nMAssay Description:The human PDE4D catalytic domain (UniProt no. Q08499 [S380-L740]) was incubated with a mixture of non-labelled cAMP (cyclic adenosine monophosphate) ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2022
Entry Details
Go to US Patent

TargetTumor necrosis factor(Human)
Union Therapeutics

US Patent
LigandPNGBDBM558649(US11365204, Example 4 | [1-[(5R)-4-[Methyl(tetrahy...)
Affinity DataIC50: 100nMAssay Description:Human peripheral blood mononuclear cells (PBMC) were isolated from fresh buffy coats by density centrifugation using lymphoprep tubes (Medinor). Froz...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2022
Entry Details
Go to US Patent

TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4D(Human)
Union Therapeutics

US Patent
LigandPNGBDBM558650(US11365204, Example 5 | [1-[4-[Methyl(tetrahydropy...)
Affinity DataIC50: 100nMAssay Description:The human PDE4D catalytic domain (UniProt no. Q08499 [S380-L740]) was incubated with a mixture of non-labelled cAMP (cyclic adenosine monophosphate) ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2022
Entry Details
Go to US Patent

TargetTumor necrosis factor(Human)
Union Therapeutics

US Patent
LigandPNGBDBM558650(US11365204, Example 5 | [1-[4-[Methyl(tetrahydropy...)
Affinity DataIC50: 100nMAssay Description:Human peripheral blood mononuclear cells (PBMC) were isolated from fresh buffy coats by density centrifugation using lymphoprep tubes (Medinor). Froz...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2022
Entry Details
Go to US Patent

TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4D(Human)
Union Therapeutics

US Patent
LigandPNGBDBM558651(US11365204, Example 6 | [1-[(5R)-4-[Methyl(tetrahy...)
Affinity DataIC50: 100nMAssay Description:The human PDE4D catalytic domain (UniProt no. Q08499 [S380-L740]) was incubated with a mixture of non-labelled cAMP (cyclic adenosine monophosphate) ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2022
Entry Details
Go to US Patent

TargetTumor necrosis factor(Human)
Union Therapeutics

US Patent
LigandPNGBDBM558651(US11365204, Example 6 | [1-[(5R)-4-[Methyl(tetrahy...)
Affinity DataIC50: 100nMAssay Description:Human peripheral blood mononuclear cells (PBMC) were isolated from fresh buffy coats by density centrifugation using lymphoprep tubes (Medinor). Froz...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2022
Entry Details
Go to US Patent

TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4D(Human)
Union Therapeutics

US Patent
LigandPNGBDBM558656(US11365204, Example 11 | [1-[(5R)-5-oxido-4- (tetr...)
Affinity DataIC50: 100nMAssay Description:The human PDE4D catalytic domain (UniProt no. Q08499 [S380-L740]) was incubated with a mixture of non-labelled cAMP (cyclic adenosine monophosphate) ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2022
Entry Details
Go to US Patent

TargetTumor necrosis factor(Human)
Union Therapeutics

US Patent
LigandPNGBDBM558656(US11365204, Example 11 | [1-[(5R)-5-oxido-4- (tetr...)
Affinity DataIC50: 100nMAssay Description:Human peripheral blood mononuclear cells (PBMC) were isolated from fresh buffy coats by density centrifugation using lymphoprep tubes (Medinor). Froz...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2022
Entry Details
Go to US Patent

TargetTumor necrosis factor(Human)
Union Therapeutics

US Patent
LigandPNGBDBM558657(US11365204, Example 12 | [1-[(5R)-5-oxido-4- (tetr...)
Affinity DataIC50: 100nMAssay Description:Human peripheral blood mononuclear cells (PBMC) were isolated from fresh buffy coats by density centrifugation using lymphoprep tubes (Medinor). Froz...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2022
Entry Details
Go to US Patent

TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4D(Human)
Union Therapeutics

US Patent
LigandPNGBDBM558660(US11365204, Example 15 | [1-[4-[methyl(tetra- hydr...)
Affinity DataIC50: 100nMAssay Description:The human PDE4D catalytic domain (UniProt no. Q08499 [S380-L740]) was incubated with a mixture of non-labelled cAMP (cyclic adenosine monophosphate) ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2022
Entry Details
Go to US Patent

TargetTumor necrosis factor(Human)
Union Therapeutics

US Patent
LigandPNGBDBM558660(US11365204, Example 15 | [1-[4-[methyl(tetra- hydr...)
Affinity DataIC50: 100nMAssay Description:Human peripheral blood mononuclear cells (PBMC) were isolated from fresh buffy coats by density centrifugation using lymphoprep tubes (Medinor). Froz...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2022
Entry Details
Go to US Patent

TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4D(Human)
Union Therapeutics

US Patent
LigandPNGBDBM558661(US11365204, Example 16 | [1-[4-[methyl(tetra- hydr...)
Affinity DataIC50: 100nMAssay Description:The human PDE4D catalytic domain (UniProt no. Q08499 [S380-L740]) was incubated with a mixture of non-labelled cAMP (cyclic adenosine monophosphate) ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2022
Entry Details
Go to US Patent

TargetTumor necrosis factor(Human)
Union Therapeutics

US Patent
LigandPNGBDBM558661(US11365204, Example 16 | [1-[4-[methyl(tetra- hydr...)
Affinity DataIC50: 100nMAssay Description:Human peripheral blood mononuclear cells (PBMC) were isolated from fresh buffy coats by density centrifugation using lymphoprep tubes (Medinor). Froz...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2022
Entry Details
Go to US Patent

TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4D(Human)
Union Therapeutics

US Patent
LigandPNGBDBM558662(US11365204, Example 17 | [1-[4-[methyl(tetra- hydr...)
Affinity DataIC50: 100nMAssay Description:The human PDE4D catalytic domain (UniProt no. Q08499 [S380-L740]) was incubated with a mixture of non-labelled cAMP (cyclic adenosine monophosphate) ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2022
Entry Details
Go to US Patent

TargetTumor necrosis factor(Human)
Union Therapeutics

US Patent
LigandPNGBDBM558662(US11365204, Example 17 | [1-[4-[methyl(tetra- hydr...)
Affinity DataIC50: 100nMAssay Description:Human peripheral blood mononuclear cells (PBMC) were isolated from fresh buffy coats by density centrifugation using lymphoprep tubes (Medinor). Froz...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2022
Entry Details
Go to US Patent

TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4D(Human)
Union Therapeutics

US Patent
LigandPNGBDBM558663(US11365204, Example 18 | [1-[4-[methyl(tetra- hydr...)
Affinity DataIC50: 100nMAssay Description:The human PDE4D catalytic domain (UniProt no. Q08499 [S380-L740]) was incubated with a mixture of non-labelled cAMP (cyclic adenosine monophosphate) ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2022
Entry Details
Go to US Patent

TargetTumor necrosis factor(Human)
Union Therapeutics

US Patent
LigandPNGBDBM558663(US11365204, Example 18 | [1-[4-[methyl(tetra- hydr...)
Affinity DataIC50: 100nMAssay Description:Human peripheral blood mononuclear cells (PBMC) were isolated from fresh buffy coats by density centrifugation using lymphoprep tubes (Medinor). Froz...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2022
Entry Details
Go to US Patent

TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4D(Human)
Union Therapeutics

US Patent
LigandPNGBDBM558664(US11365204, Example 19 | [1-[4-[methyl(tetra- hydr...)
Affinity DataIC50: 100nMAssay Description:The human PDE4D catalytic domain (UniProt no. Q08499 [S380-L740]) was incubated with a mixture of non-labelled cAMP (cyclic adenosine monophosphate) ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2022
Entry Details
Go to US Patent

TargetTumor necrosis factor(Human)
Union Therapeutics

US Patent
LigandPNGBDBM558664(US11365204, Example 19 | [1-[4-[methyl(tetra- hydr...)
Affinity DataIC50: 100nMAssay Description:Human peripheral blood mononuclear cells (PBMC) were isolated from fresh buffy coats by density centrifugation using lymphoprep tubes (Medinor). Froz...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2022
Entry Details
Go to US Patent

TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4D(Human)
Union Therapeutics

US Patent
LigandPNGBDBM558665(US11365204, Example 20 | [1-[4-[methyl(tetra- hydr...)
Affinity DataIC50: 100nMAssay Description:The human PDE4D catalytic domain (UniProt no. Q08499 [S380-L740]) was incubated with a mixture of non-labelled cAMP (cyclic adenosine monophosphate) ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2022
Entry Details
Go to US Patent

TargetTumor necrosis factor(Human)
Union Therapeutics

US Patent
LigandPNGBDBM558665(US11365204, Example 20 | [1-[4-[methyl(tetra- hydr...)
Affinity DataIC50: 100nMAssay Description:Human peripheral blood mononuclear cells (PBMC) were isolated from fresh buffy coats by density centrifugation using lymphoprep tubes (Medinor). Froz...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2022
Entry Details
Go to US Patent

TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4D(Human)
Union Therapeutics

US Patent
LigandPNGBDBM558666(US11365204, Example 21 | [1-[4-[methyl(tetra- hydr...)
Affinity DataIC50: 100nMAssay Description:The human PDE4D catalytic domain (UniProt no. Q08499 [S380-L740]) was incubated with a mixture of non-labelled cAMP (cyclic adenosine monophosphate) ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2022
Entry Details
Go to US Patent

TargetTumor necrosis factor(Human)
Union Therapeutics

US Patent
LigandPNGBDBM558666(US11365204, Example 21 | [1-[4-[methyl(tetra- hydr...)
Affinity DataIC50: 100nMAssay Description:Human peripheral blood mononuclear cells (PBMC) were isolated from fresh buffy coats by density centrifugation using lymphoprep tubes (Medinor). Froz...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2022
Entry Details
Go to US Patent

TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4D(Human)
Union Therapeutics

US Patent
LigandPNGBDBM558667(US11365204, Example 22 | [1-[4-[methyl(tetra- hydr...)
Affinity DataIC50: 100nMAssay Description:The human PDE4D catalytic domain (UniProt no. Q08499 [S380-L740]) was incubated with a mixture of non-labelled cAMP (cyclic adenosine monophosphate) ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2022
Entry Details
Go to US Patent

TargetTumor necrosis factor(Human)
Union Therapeutics

US Patent
LigandPNGBDBM558667(US11365204, Example 22 | [1-[4-[methyl(tetra- hydr...)
Affinity DataIC50: 100nMAssay Description:Human peripheral blood mononuclear cells (PBMC) were isolated from fresh buffy coats by density centrifugation using lymphoprep tubes (Medinor). Froz...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2022
Entry Details
Go to US Patent

TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4D(Human)
Union Therapeutics

US Patent
LigandPNGBDBM558668(US11365204, Example 23 | [1-[4-[methyl(tetra- hydr...)
Affinity DataIC50: 100nMAssay Description:The human PDE4D catalytic domain (UniProt no. Q08499 [S380-L740]) was incubated with a mixture of non-labelled cAMP (cyclic adenosine monophosphate) ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2022
Entry Details
Go to US Patent

TargetTumor necrosis factor(Human)
Union Therapeutics

US Patent
LigandPNGBDBM558668(US11365204, Example 23 | [1-[4-[methyl(tetra- hydr...)
Affinity DataIC50: 100nMAssay Description:Human peripheral blood mononuclear cells (PBMC) were isolated from fresh buffy coats by density centrifugation using lymphoprep tubes (Medinor). Froz...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2022
Entry Details
Go to US Patent

TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4D(Human)
Union Therapeutics

US Patent
LigandPNGBDBM558669(US11365204, Example 24 | [1-[4-[methyl(tetra- hydr...)
Affinity DataIC50: 100nMAssay Description:The human PDE4D catalytic domain (UniProt no. Q08499 [S380-L740]) was incubated with a mixture of non-labelled cAMP (cyclic adenosine monophosphate) ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2022
Entry Details
Go to US Patent

TargetTumor necrosis factor(Human)
Union Therapeutics

US Patent
LigandPNGBDBM558669(US11365204, Example 24 | [1-[4-[methyl(tetra- hydr...)
Affinity DataIC50: 100nMAssay Description:Human peripheral blood mononuclear cells (PBMC) were isolated from fresh buffy coats by density centrifugation using lymphoprep tubes (Medinor). Froz...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2022
Entry Details
Go to US Patent

TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4D(Human)
Union Therapeutics

US Patent
LigandPNGBDBM558670(US11365204, Example 25 | [1-[4-[methyl(tetra- hydr...)
Affinity DataIC50: 100nMAssay Description:The human PDE4D catalytic domain (UniProt no. Q08499 [S380-L740]) was incubated with a mixture of non-labelled cAMP (cyclic adenosine monophosphate) ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2022
Entry Details
Go to US Patent

TargetTumor necrosis factor(Human)
Union Therapeutics

US Patent
LigandPNGBDBM558670(US11365204, Example 25 | [1-[4-[methyl(tetra- hydr...)
Affinity DataIC50: 100nMAssay Description:Human peripheral blood mononuclear cells (PBMC) were isolated from fresh buffy coats by density centrifugation using lymphoprep tubes (Medinor). Froz...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2022
Entry Details
Go to US Patent

TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4D(Human)
Union Therapeutics

US Patent
LigandPNGBDBM558671(US11365204, Example 26 | [1-[4-[methyl(tetra- hydr...)
Affinity DataIC50: 100nMAssay Description:The human PDE4D catalytic domain (UniProt no. Q08499 [S380-L740]) was incubated with a mixture of non-labelled cAMP (cyclic adenosine monophosphate) ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2022
Entry Details
Go to US Patent

TargetTumor necrosis factor(Human)
Union Therapeutics

US Patent
LigandPNGBDBM558671(US11365204, Example 26 | [1-[4-[methyl(tetra- hydr...)
Affinity DataIC50: 100nMAssay Description:Human peripheral blood mononuclear cells (PBMC) were isolated from fresh buffy coats by density centrifugation using lymphoprep tubes (Medinor). Froz...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2022
Entry Details
Go to US Patent

TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4D(Human)
Union Therapeutics

US Patent
LigandPNGBDBM558672(US11365204, Example 27 | [1-[4-[methyl(tetra- hydr...)
Affinity DataIC50: 100nMAssay Description:The human PDE4D catalytic domain (UniProt no. Q08499 [S380-L740]) was incubated with a mixture of non-labelled cAMP (cyclic adenosine monophosphate) ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2022
Entry Details
Go to US Patent

TargetTumor necrosis factor(Human)
Union Therapeutics

US Patent
LigandPNGBDBM558672(US11365204, Example 27 | [1-[4-[methyl(tetra- hydr...)
Affinity DataIC50: 100nMAssay Description:Human peripheral blood mononuclear cells (PBMC) were isolated from fresh buffy coats by density centrifugation using lymphoprep tubes (Medinor). Froz...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2022
Entry Details
Go to US Patent

TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4D(Human)
Union Therapeutics

US Patent
LigandPNGBDBM558673(US11365204, Example 28 | [1-[4-[methyl(tetra- hydr...)
Affinity DataIC50: 100nMAssay Description:The human PDE4D catalytic domain (UniProt no. Q08499 [S380-L740]) was incubated with a mixture of non-labelled cAMP (cyclic adenosine monophosphate) ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2022
Entry Details
Go to US Patent

TargetTumor necrosis factor(Human)
Union Therapeutics

US Patent
LigandPNGBDBM558673(US11365204, Example 28 | [1-[4-[methyl(tetra- hydr...)
Affinity DataIC50: 100nMAssay Description:Human peripheral blood mononuclear cells (PBMC) were isolated from fresh buffy coats by density centrifugation using lymphoprep tubes (Medinor). Froz...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2022
Entry Details
Go to US Patent

TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4D(Human)
Union Therapeutics

US Patent
LigandPNGBDBM558674(US11365204, Example 29 | [1-[4-[methyl(tetra- hydr...)
Affinity DataIC50: 100nMAssay Description:The human PDE4D catalytic domain (UniProt no. Q08499 [S380-L740]) was incubated with a mixture of non-labelled cAMP (cyclic adenosine monophosphate) ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2022
Entry Details
Go to US Patent

TargetTumor necrosis factor(Human)
Union Therapeutics

US Patent
LigandPNGBDBM558674(US11365204, Example 29 | [1-[4-[methyl(tetra- hydr...)
Affinity DataIC50: 100nMAssay Description:Human peripheral blood mononuclear cells (PBMC) were isolated from fresh buffy coats by density centrifugation using lymphoprep tubes (Medinor). Froz...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2022
Entry Details
Go to US Patent

TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4D(Human)
Union Therapeutics

US Patent
LigandPNGBDBM558675(US11365204, Example 30 | [1-[4-[methyl(tetra- hydr...)
Affinity DataIC50: 100nMAssay Description:The human PDE4D catalytic domain (UniProt no. Q08499 [S380-L740]) was incubated with a mixture of non-labelled cAMP (cyclic adenosine monophosphate) ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2022
Entry Details
Go to US Patent

TargetTumor necrosis factor(Human)
Union Therapeutics

US Patent
LigandPNGBDBM558675(US11365204, Example 30 | [1-[4-[methyl(tetra- hydr...)
Affinity DataIC50: 100nMAssay Description:Human peripheral blood mononuclear cells (PBMC) were isolated from fresh buffy coats by density centrifugation using lymphoprep tubes (Medinor). Froz...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2022
Entry Details
Go to US Patent

TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4D(Human)
Union Therapeutics

US Patent
LigandPNGBDBM558676(US11365204, Example 31 | [1-[4-[methyl(tetra- hydr...)
Affinity DataIC50: 100nMAssay Description:The human PDE4D catalytic domain (UniProt no. Q08499 [S380-L740]) was incubated with a mixture of non-labelled cAMP (cyclic adenosine monophosphate) ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2022
Entry Details
Go to US Patent

TargetTumor necrosis factor(Human)
Union Therapeutics

US Patent
LigandPNGBDBM558676(US11365204, Example 31 | [1-[4-[methyl(tetra- hydr...)
Affinity DataIC50: 100nMAssay Description:Human peripheral blood mononuclear cells (PBMC) were isolated from fresh buffy coats by density centrifugation using lymphoprep tubes (Medinor). Froz...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2022
Entry Details
Go to US Patent

TargetcAMP-specific 3',5'-cyclic phosphodiesterase 4D(Human)
Union Therapeutics

US Patent
LigandPNGBDBM558677(US11365204, Example 32 | [1-[4-[methyl(tetra- hydr...)
Affinity DataIC50: 100nMAssay Description:The human PDE4D catalytic domain (UniProt no. Q08499 [S380-L740]) was incubated with a mixture of non-labelled cAMP (cyclic adenosine monophosphate) ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2022
Entry Details
Go to US Patent

Displayed 1 to 50 (of 154 total ) | Next | Last >>
Jump to: